➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for DEBIO-1347

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for DEBIO-1347?

DEBIO-1347 is an investigational drug.

There have been 20 clinical trials for DEBIO-1347. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2007.

The most common disease conditions in clinical trials are Bacterial Infections, Hepatitis C, Chronic, and Infection. The leading clinical trial sponsors are Debiopharm International SA, INC Research, and Parexel.

Recent Clinical Trials for DEBIO-1347
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid TumorsDebiopharm International SAPhase 1
Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143Debiopharm International SAPhase 1/Phase 2
Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic AdenocarcinomaDebiopharm International SAPhase 1

See all DEBIO-1347 clinical trials

Clinical Trial Summary for DEBIO-1347

Top disease conditions for DEBIO-1347
Top clinical trial sponsors for DEBIO-1347

See all DEBIO-1347 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.